(NASDAQ: INBS) Intelligent Bio Solutions's forecast annual revenue growth rate of 33.92% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.03%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12%.
Intelligent Bio Solutions's revenue in 2026 is $5,185,223.On average, 3 Wall Street analysts forecast INBS's revenue for 2027 to be $20,637,148, with the lowest INBS revenue forecast at $19,827,848, and the highest INBS revenue forecast at $21,244,123. On average, 3 Wall Street analysts forecast INBS's revenue for 2028 to be $29,771,624, with the lowest INBS revenue forecast at $28,604,109, and the highest INBS revenue forecast at $30,647,260.
In 2029, INBS is forecast to generate $41,781,767 in revenue, with the lowest revenue forecast at $40,143,267 and the highest revenue forecast at $43,012,301.